| 000 | 01123 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250512003706.0 | ||
| 264 | 0 | _c19890921 | |
| 008 | 198909s 0 0 eng d | ||
| 022 | _a0009-9236 | ||
| 024 | 7 |
_a10.1038/clpt.1989.120 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTanswell, P | |
| 245 | 0 | 0 |
_aPharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjects. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cAug 1989 |
||
| 300 |
_a155-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aHemostasis _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacokinetics |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xantagonists & inhibitors |
| 700 | 1 | _aSeifried, E | |
| 700 | 1 | _aSu, P C | |
| 700 | 1 | _aFeuerer, W | |
| 700 | 1 | _aRijken, D C | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 46 _gno. 2 _gp. 155-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/clpt.1989.120 _zAvailable from publisher's website |
| 999 |
_c2509277 _d2509277 |
||